Drug General Information
Drug ID	D05OML
Former ID	DNC014398
Drug Name	5-(3-hydroxyphenyl)-1,3,4-oxadiazole-2(3H)-thione
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[530900]
Structure		Download 2D MOL 3D MOL
Formula	C8H6N2O2S
Canonical SMILES	C1=CC(=CC(=C1)O)C2=NNC(=S)O2
InChI	1S/C8H6N2O2S/c11-6-3-1-2-5(4-6)7-9-10-8(13)12-7/h1-4,11H,(H,10,13)
InChIKey	CNOGHDSTUCQSOV-UHFFFAOYSA-N
PubChem Compound ID	745318
Target and Pathway
Target(s)	Tyrosine oxidase	Target Info	Inhibitor	[530900]
BioCyc Pathway	(S)-reticuline biosynthesis
	Eumelanin biosynthesis
	L-dopachrome biosynthesis
KEGG Pathway	Tyrosine metabolism
	Riboflavin metabolism
	Metabolic pathways
	Melanogenesis
PathWhiz Pathway	Riboflavin Metabolism
	Tyrosine Metabolism
WikiPathways	Dopamine metabolism
References
Ref 530900	Bioorg Med Chem. 2010 Jun 1;18(11):4042-8. Epub 2010 Apr 13.New potent inhibitors of tyrosinase: novel clues to binding of 1,3,4-thiadiazole-2(3H)-thiones, 1,3,4-oxadiazole-2(3H)-thiones, 4-amino-1,2,4-triazole-5(4H)-thiones, and substituted hydrazides to the dicopper active site.
Ref 530900	Bioorg Med Chem. 2010 Jun 1;18(11):4042-8. Epub 2010 Apr 13.New potent inhibitors of tyrosinase: novel clues to binding of 1,3,4-thiadiazole-2(3H)-thiones, 1,3,4-oxadiazole-2(3H)-thiones, 4-amino-1,2,4-triazole-5(4H)-thiones, and substituted hydrazides to the dicopper active site.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.